TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection

Clinical trial NCT00442832 · COMPLETED

Trial details

NCT number: NCT00442832
Sponsor: Theravance Biopharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcal Skin Infection

Start date: 2006-12-01
Primary completion: 2007-05-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.